North Point Portfolio Managers Corp Regeneron Pharmaceuticals, Inc. Transaction History

North Point Portfolio Managers Corp

  • $590 Million
  • Q3 2024

A detailed history of North Point Portfolio Managers Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, North Point Portfolio Managers Corp holds 17,306 shares of REGN stock, worth $14.1 Million. This represents 3.08% of its overall portfolio holdings.

Number of Shares
17,306
Previous 17,338 0.18%
Holding current value
$14.1 Million
Previous $18.2 Million 0.16%
% of portfolio
3.08%
Previous 3.24%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$1024.09 - $1201.76 $32,770 - $38,456
-32 Reduced 0.18%
17,306 $18.2 Million
Q2 2024

Jul 29, 2024
SELL
$883.2 - $1071.19 $598,809 - $726,266
-678 Reduced 3.76%
17,338 $18.2 Million
Q1 2024

Apr 23, 2024
BUY
$902.69 - $993.35 $58,674 - $64,567
65 Added 0.36%
18,016 $17.3 Million
Q4 2023

Jan 23, 2024
BUY
$775.18 - $881.7 $10,077 - $11,462
13 Added 0.07%
17,951 $15.8 Million
Q3 2023

Oct 26, 2023
SELL
$692.45 - $844.37 $12,464 - $15,198
-18 Reduced 0.1%
17,938 $14.8 Million
Q2 2023

Jul 24, 2023
SELL
$700.03 - $830.35 $3.59 Million - $4.25 Million
-5,124 Reduced 22.2%
17,956 $12.9 Million
Q1 2023

Apr 25, 2023
BUY
$680.49 - $826.97 $38,787 - $47,137
57 Added 0.25%
23,080 $19 Million
Q4 2022

Jan 24, 2023
BUY
$705.89 - $766.39 $95,295 - $103,462
135 Added 0.59%
23,023 $0
Q3 2022

Oct 25, 2022
SELL
$573.97 - $724.32 $222,700 - $281,036
-388 Reduced 1.67%
22,888 $15.8 Million
Q2 2022

Jul 27, 2022
SELL
$548.35 - $738.84 $213,856 - $288,147
-390 Reduced 1.65%
23,276 $13.8 Million
Q1 2022

Apr 26, 2022
SELL
$595.12 - $698.43 $14,878 - $17,460
-25 Reduced 0.11%
23,666 $16.5 Million
Q4 2021

Jan 26, 2022
SELL
$543.48 - $670.97 $503,262 - $621,318
-926 Reduced 3.76%
23,691 $15 Million
Q3 2021

Oct 20, 2021
SELL
$574.03 - $680.96 $136,045 - $161,387
-237 Reduced 0.95%
24,617 $14.9 Million
Q2 2021

Jul 28, 2021
BUY
$472.8 - $558.54 $19,857 - $23,458
42 Added 0.17%
24,854 $13.9 Million
Q1 2021

Apr 26, 2021
SELL
$446.73 - $548.2 $73,710 - $90,453
-165 Reduced 0.66%
24,812 $11.7 Million
Q4 2020

Jan 28, 2021
SELL
$478.3 - $607.98 $66,005 - $83,901
-138 Reduced 0.55%
24,977 $12.1 Million
Q3 2020

Oct 27, 2020
SELL
$544.75 - $658.21 $6.05 Million - $7.31 Million
-11,100 Reduced 30.65%
25,115 $14.1 Million
Q2 2020

Jul 28, 2020
SELL
$493.32 - $643.92 $1.7 Million - $2.22 Million
-3,442 Reduced 8.68%
36,215 $22.6 Million
Q1 2020

Apr 28, 2020
SELL
$336.18 - $494.43 $88,079 - $129,540
-262 Reduced 0.66%
39,657 $19.4 Million
Q4 2019

Feb 20, 2020
SELL
$274.13 - $376.51 $469,310 - $644,585
-1,712 Reduced 4.11%
39,919 $15 Million
Q3 2019

Oct 31, 2019
BUY
$273.46 - $318.39 $929,763 - $1.08 Million
3,400 Added 8.89%
41,631 $11.5 Million
Q2 2019

Aug 02, 2019
BUY
$299.6 - $414.82 $3.12 Million - $4.32 Million
10,412 Added 37.43%
38,231 $12 Million
Q1 2019

Apr 24, 2019
BUY
$372.08 - $439.57 $53,207 - $62,858
143 Added 0.52%
27,819 $11.4 Million
Q4 2018

Jan 24, 2019
SELL
$335.82 - $403.04 $511,453 - $613,829
-1,523 Reduced 5.22%
27,676 $10.3 Million
Q3 2018

Oct 26, 2018
BUY
$351.14 - $408.51 $20,366 - $23,693
58 Added 0.2%
29,199 $11.8 Million
Q2 2018

Jul 26, 2018
SELL
$284.6 - $344.99 $105,017 - $127,301
-369 Reduced 1.25%
29,141 $10.1 Million
Q1 2018

Apr 25, 2018
BUY
$315.82 - $393.78 $198,650 - $247,687
629 Added 2.18%
29,510 $10.2 Million
Q4 2017

Jan 24, 2018
SELL
$358.63 - $469.95 $511,047 - $669,678
-1,425 Reduced 4.7%
28,881 $10.9 Million
Q3 2017

Oct 30, 2017
BUY
$431.38 - $504.0 $13.1 Million - $15.3 Million
30,306
30,306 $13.6 Million

Others Institutions Holding REGN

# of Institutions
1,490
Shares Held
85.8M
Call Options Held
908K
Put Options Held
1.3M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $87.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track North Point Portfolio Managers Corp Portfolio

Follow North Point Portfolio Managers Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Point Portfolio Managers Corp, based on Form 13F filings with the SEC.

News

Stay updated on North Point Portfolio Managers Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email